Nutex Securities Class Action Reaches Lead Plaintiff Deadline Today
The case centers on claims that Nutex relied on HaloMD’s insurance arbitration results to inflate revenue.
Overview
- The lawsuit is filed in the U.S. District Court for the Southern District of Texas for investors who bought Nutex shares between August 8, 2024 and August 14, 2025.
- Plaintiffs allege a coordinated scheme with third‑party vendor HaloMD to submit ineligible claims through the IDR process, rendering arbitration‑driven revenue unsustainable.
- The complaint further alleges overstated remediation of internal control weaknesses and improper classification of certain stock‑based compensation as equity rather than liabilities.
- Nutex disclosed a Form 10‑Q filing delay on August 14 and later reported an Audit Committee determination that prior financial statements require restatement.
- A July 22 short‑seller report by Blue Orca preceded notable share declines, multiple firms are urging investors to seek lead‑plaintiff appointment by October 21, and no class has been certified.